# V1 Empirics Check — x-ai/grok-4.1-fast (Variant C)

**Model:** x-ai/grok-4.1-fast
**Variant:** C
**Date:** 2026-03-30T10:27:33.398669

---

### 1. Idea Fidelity
The paper partially pursues the original idea manifest but deviates substantially from the core identification strategy. The manifest promised a two-way fixed effects DiD using 316 England/Wales (E/W) local authorities (LAs) as treated units and 32 Scottish LAs as controls, with treatment at May 2021, pre-period 2015–2020, post-period 2021–2024, and controls (IMD/SIMD, unemployment, population). Instead, the paper (i) restricts to 303 E/W LAs only for the primary dose-response design (pre-intensity × post-2021), (ii) uses aggregate national E/W vs. Scotland DiD as complementary (not LA-level), (iii) omits controls from regressions, (iv) shortens post-period to 2023, and (v) lacks an event study (only mentions placebo at 2018). It misses the manifest's border DiD promise, using Scotland only descriptively/nationally, weakening causal claims. Data sources match, but the research question shifts from policy effect on total insolvency to composition shift.

### 2. Summary
This paper evaluates the UK's Breathing Space debt moratorium (May 2021, E/W only) using LA-level administrative data (2015–2023). It finds no reduction in total personal insolvency rates but a composition shift: bankruptcies fell sharply (UK-wide trend), offset by IVA increases specific to E/W, via dose-response (pre-insolvency intensity × post) and national E/W-Scotland DiD. The result implies moratoria act as "sorting mechanisms" rather than prevention tools, with policy implications for debtor welfare and global debt relief design.

### 3. Essential Points
**1. Weak primary identification undermines causal claims.** The dose-response (pre-2015–2019 intensity × post-2021) within E/W LAs tests for differential convergence/mean reversion post-policy, not a clean policy effect (no untreated variation within E/W). High pre-intensity LAs were already diverging upward pre-2021 (placebo β=0.178, p<0.001 for total), so the post-shift partly reflects mechanical reversion, not Breathing Space causality. Authors must either revert to manifest's LA-level E/W-Scotland DiD (using Scotland's 32 LAs) or explicitly reframe as a descriptive convergence test, with bounds on policy attribution.

**2. No parallel trends validation.** No event study or graphical pre-trends are shown; the placebo hints at violation (positive pre-divergence). Must add event study plots and leads/lags regression for dose-response (e.g., bin pre-intensity and plot coefficients by year relative to 2021) to justify TWFE extrapolation.

**3. Omission of promised controls biases results.** Manifest specified IMD/SIMD, unemployment, and population controls, but regressions include none. Pre-intensity likely proxies these (e.g., correlates with deprivation), inflating β and shrinking SEs. Include them explicitly; if insignificant, report and discuss.

Failure to address 1–2 warrants rejection; 3 is fixable.

### 4. Suggestions
**Strengthen identification and robustness (priority).** Implement the manifest's LA-level DiD: pool 303 E/W + 32 Scotland LAs, interact E/W dummy × post-2021 (or monthly post-May 2021 using national CSV), weighting by adult population. Scotland's Statutory Moratorium (2008) parallels Breathing Space, so test heterogeneity by insolvency type (sequestration vs. bankruptcies; Protected Trust Deeds vs. IVAs; DAS vs. DROs). Use Scotland LA data (AiB XLSX confirmed available) for TWFE with LA/year FEs. For dose-response, normalize pre-intensity by type (e.g., pre-bankruptcy rate × post for bankruptcies) to sharpen composition claims. Add permutation test (manifest): randomly assign 32 "Scottish" LAs from E/W pool, repeat 1,000×.

**Validate assumptions rigorously.** Plot raw trends: pre/post means by pre-intensity terciles (high/medium/low) for total and types; add Scotland national/LA trends overlay. Event study: replace post dummy with leads/lags, e.g., ∑_k β_k (pre-intensity × year_k), testing β_{pre}=0 jointly. Exclude 2020–2021 (COVID/furlough) baseline; test 2022–2023 only. Address DRO threshold hike (Jun 2021, £30k): interact post × DRO-eligible proxy (e.g., low-asset LAs via IMD). Cluster SEs two-way (LA-year) or wild bootstrap for small post-N (3 years).

**Magnitudes and SEs: plausible but refine presentation.** Effects are economically meaningful: bankruptcy SDE=-0.38 (large), IVA +0.11 (moderate), netting to null total—clear "sorting" story. Halving bankruptcies (14.6→7.3/10k adults) aligns with raw UK-wide drop (Scotland -45%), IVA +24% matches BS take-up (~60/10k). SEs appropriate (clustered LA-level, N=303, balanced panel): bankruptcy SE=0.0037 yields precise p<0.001 despite low mean/SD (power from TWFE). But placebo's large pre-β highlights extrapolation risk. Add Appendix Table: (i) unstandardized effects at mean/SD pre-intensity (e.g., high-intensity LA: -2.1 bankruptcies/10k post); (ii) power calculations for national DiD (detect 10% effect at 80% power?); (iii) falsification on non-insolvency outcomes (e.g., unemployment rates).

**Data and descriptives enhancements.** Use full 2014–2024/2025 (manifest): annualize May 2021+ via monthly CSV (312 rows). Report BS intensity directly: replace pre-insolvency with post-BS registrations × post (but instrument with pre-intensity to avoid endo). Table 1: add Scotland column. Map cross-LA BS variation (6–56/10k). Controls table: pre/post means by tercile. Heterogeneity: split London vs. non-London (Appendix shows null/moderate); by IMD quintile.

**Economic interpretation and policy.** Lean into composition: quantify "offset" (e.g., -6.3 bankruptcies +8.4 IVAs = +2.1 net via simulation). Welfare calc: back-of-envelope IVA fees (25–30% of payments) vs. bankruptcy discharge speed, citing Walters (2019). Global angle strong—contrast US Ch.13 (Dobbie et al.), India waiver. Policy: simulate "not-for-profit IVA referral" counterfactual.

**Writing and AER:Insights polish.** Tighten abstract: lead with null total + composition. Intro: quantify BS scale (300k users) vs. insolvencies (~250k/year E/W). Move national DiD to main (Table 1), dose-response to Table 2. Appendix: full robustness suite (event study, controls, monthly). Citations good; add \citet{checker2022} on UK COVID insolvencies. Total length fits (short); execution time note amusing but remove for submission.

Overall, strong descriptive contribution with fixable causal gaps—revise and resubmit potential high.
